Portal for life science/healthcare startups
  • Home
    • English Top
    • 日本語トップ
  • Table of Contents (English)
    • Business Setup & Operations >
      • Startup Visa
      • setup corporation, office in Japan
      • Company establishment
      • Life Science Hub, Startup Hub
    • Public Support >
      • List of Public Support Organizations
      • Public Support in Yokohama city
      • Academia-Based Startup Support Guide
      • Mediso free consultation service
    • Regulatory & Compliance >
      • PMDA consultation
      • regulatory considerations when using person infformation
      • Guide to Selecting Regulatory Affairs Staff and Consultants
      • Expedited Review Systems for Pharmaceuticals
      • Guidelines for Establishing Generic Drug Names
      • Combination Products, Combination Medical Devices, Kit Products, Combination Drugs
    • Medical Device, IVD >
      • IVD, LDT, RUO
      • DMAH: Designated Marketing Authorization Holder-Summary Ver.
      • DMAH: Designated Marketing Authorization Holder
      • Combination Products, Combination Medical Devices, Kit Products, Kit Components, Assortment Products
      • How to determine if a product is a medical device
      • medical device classification for combined products
      • medical device class
      • how to confirm JMDN of medical device
      • medical device & IVD reimbursement-Summary Ver.
      • medical device & IVD reimbursemenet
      • insurance reimbursement for SaMD
      • Comparison of Medical Device Definitions: Japan, US, & EU
      • Companion Diagnostics and Gene Panel Testing
    • Pharmaceutical, regenerative medicine >
      • How to determine if a product is a Pharmaceutical Drug
      • Advanced Medical Care System
      • Over-The-Counter (OTC) Drug
      • References on Reimbursement (Cost Calculation) for Regenerative Medical Products
    • Healthcare & Caretech Products >
      • guidance for non medical services
      • Therapeutic Orthoses and Assistive Devices
      • Cosmetics and Quasi-Drugs
      • Overseas Expansion of Non-Medical Device Products as Medical Devices: Learning from the Case of PARO
    • Funding, Partnering & Networking >
      • Utilization of Public Grants and Subsidies
      • J-Ships
      • Partnering
    • Intellectual Property >
      • patent or trade secret?
      • employee invention
      • Matching of Patents Held by Startups and Individuals
    • Legal & Contracts >
      • References for Contracts
      • Guide to Industry-Academia Collaboration Agreements for Academic Researchers
    • Academia & Tech Transfer
    • Licensing, partnering >
      • Introducing Seeds to Pharmaceutical Companies
      • Incentives (Returns) to Licensor Universities
    • References in English
  • コンテンツ一覧
    • 事業設立・運営 >
      • 法人設立
      • ライフサイエンスハブ、スタートアップハブ
    • 公的支援 >
      • 公的支援機関リスト
      • 大学発スタートアップ支援機関・プログラムガイド
      • AMED Medical IP Desk
      • MEDISO活用のススメ
    • 薬事・規制関連 >
      • PMDA RS相談活用のススメ
      • 薬事スタッフ・コンサル選定ガイド
      • 都道府県薬務課一覧
      • コンビネーション製品、組合せ医療機器、キット製品、組合せ医薬品
    • 医薬品、再生医療等製品 >
      • 医薬品の該当性確認方法
      • 医薬品一般的名称設定のガイドライン
      • 医薬品、医療機器等の開発に当たって、参照したい資料
      • 先進医療制度
      • 一般用医薬品(OTC)
      • コンパニオン診断薬と遺伝子パネル検査
      • 再生医療等製品の保険償還(原価計算)に関する参考情報
    • 医療機器、体外診断用医薬品 >
      • 体外診、ラボ開発検査、研究用試薬
      • 医療機器該当性確認ガイド
      • 医療機器と非医療機器の機能が複合した製品は?
      • 医療機器の一般的名称と確認方法
      • 医療機器のクラス分類
      • 医療機器・体外診の保険収載
      • SaMDの保険収載
    • ヘルスケア・ケアテック >
      • 非医療分野の検査サービスを展開する際に注意すべきポイント
      • 治療用装具と補装具
      • 化粧品及び医薬部外品
      • 医療機器とするか、非医療機器とするか
    • 資金調達 >
      • 公的な助成金、補助金の活用
      • 特定投資家向け銘柄制度(J-Ships)
      • パートナリング
      • アカデミア研究者がPIとして応募可能なグラントリスト
      • 海外在住の日本人研究者が日本の助成金を獲得する方法
    • 知的財産 >
      • 特許か?営業秘密か?
      • 職務発明:アカデミア・公的研究機関に所属する研究者が注意すべきポ
      • スタートアップや個人が保有する特許のマッチング
      • ライセンスを受けた大学へのインセンティブ(還元)について
    • 法務・契約 >
      • 契約関連で参考になる公的機関の資料
      • 個人情報を利用する製品開発時の 留意すべき法規制
    • アカデミア、技術移転 >
      • アカデミア研究者のための産学連携契約ガイド
    • ライセンシング、パートナリング >
      • 製薬企業等へのシーズ紹介
    • 海外展開 >
      • 米国展開(主に医療機器)に、読むと役立つ情報リスト
      • 米国FDAにおける、医療機器該当性の確認ステップ
      • 米国における、医療機器の申請データ・試験計画の相談方法((Pre-Submission/Q-Submission
      • 公的機関の海外展開支援
      • 横浜市の公的支援サービス
      • JETROを徹底活用しよう
      • 日米欧での医療機器定義の比較
      • 簡略審査(審査の迅速化)
      • 海外規制等の情報収集
      • 非医療機器製品の海外での医療機器展開
    • オーストラリア >
      • オーストラリア研究開発優遇税制の概要
      • オーストラリア研究開発優遇税制の適用を受けるには
      • オーストラリアでの主要イベント
      • R&D関連の公的機関
      • オーストラリア助成金情報

Guide to Selecting Regulatory Affairs Staff and Consultants

When developing products like medical devices and pharmaceuticals, navigating regulatory affairs is unavoidable. On the other hand, simply outsourcing everything can lead to enormous costs.


What to Know Before You Hire
Hiring a regulatory affairs expert or consultant just because you're unfamiliar with the field might be a bit premature. It's best to carefully consider if it's truly necessary before making a move.

First, you need to ask yourself whether a startup should handle its own regulatory approval applications at all. For pharmaceutical startups, it's common to handle development up to a certain point and then license the product out to a major pharmaceutical company, eliminating the need for an in-house regulatory team. Similarly, many medical device startups lack the resources and network for the entire process, so they often entrust the regulatory application and sales to a company that already holds a marketing authorization license and has established sales channels.

During the business planning stage, you should decide how much of the process your company will handle and plan your regulatory resources accordingly.

Next, let's assume your company does need to handle regulatory tasks internally.
In reality, it's quite common for someone with no prior experience to take on the regulatory role at a startup. There are a few reasons why this is possible.

One reason is that, to gain regulatory approval, you must reach a prior agreement with the PMDA (Pharmaceuticals and Medical Devices Agency) for anything you do. No matter what advice a regulatory consultant gives, the final decision-maker is the regulatory authority (PMDA). This means that even if you hire regulatory staff or a consultant, they will ultimately need to consult with the PMDA anyway.

Another reason, as mentioned in other content, is that public institutions now offer free information, advice, and even hands-on support. At MEDISO, for example, they can attend PMDA meetings with you from a neutral standpoint if you wish, and they can help you reconfirm what was discussed in follow-up meetings. Therefore, a startup's basic stance should be to get information and advice for free from public bodies and pay consultants for the actual hands-on work.

Furthermore, the PMDA offers "RS Consultations," which are specifically designed for academia and startups with limited regulatory experience. In the initial comprehensive RS Consultation, they will even advise you on how to proceed with future consultations.

Given all this, hiring an experienced regulatory person or consultant to handle the practical tasks offers the best cost and time performance only when your company truly lacks the internal resources to manage anything on its own.


First, Clarify Your Company's Needs
The first step is to objectively assess your company's situation and specify what you cannot do internally. Let's break down your current situation and challenges from the following perspectives.
  • What is your business phase?
    • Clarify whether your product development is at the idea stage, basic research, initial design, non-clinical trials, or clinical trial preparation. The required tasks will vary greatly depending on the phase.
  • What specific expertise are you lacking?
    • Identify the specific knowledge gaps you have, whether it's related to your product's characteristics (e.g., software as a medical device, regenerative medicine, biopharmaceuticals), PMDA consultations, clinical trial design, or navigating overseas regulations.
  • Are your internal resources sufficient?
    • Check your internal structure. Do you have a dedicated person for regulatory applications? If not, is there a team member who could handle it with the right information and advice? If resources are insufficient, you will need to hire staff or a regulatory consultant to perform the hands-on work.
  • What is your biggest immediate challenge?
    • Pinpoint the biggest barrier currently hindering your business progress. This could be anything from "We don't know how to make the first contact with the PMDA" to "Past consultations didn't go well" or "We don't have the resources to prepare application documents." This will help you determine whether you need information and advice or practical, hands-on resources.
  • What is your budget and timeline?
    • Organize your financial and time constraints, such as the maximum amount you can spend on consulting and the deadlines you need to meet.
  • By analyzing these points, you can articulate the requirements for the staff or consultant you plan to hire (e.g., their field of expertise, the scope of support, their role). Creating a clear and well-defined request is the most crucial step in preventing a mismatch.


Understand the Types of Support
Once you have a clear understanding of your needs, the next step is to understand the various support models offered by regulatory consultants and find the type that fits you best.
  • Spot Consulting
    • This model provides one-off advice on specific issues or questions. It's suitable when you have a regulatory person in-house but need an expert's opinion on a specific, highly advanced topic.
  • Advisory Retainer
    • This involves ongoing strategic advice and decision-making support through regular meetings. However, the actual work is expected to be done by your company. The fee is typically a fixed monthly rate.
  • Hands-on / Project-Based Support
    • This model involves the consultant taking on or supporting the creation of specific deliverables, such as PMDA consultation documents, Quality Management System (QMS) development, or marketing approval applications. Fees are set on a per-project basis.
  • Strategic Partner
    • This offers comprehensive, long-term support across the entire business lifecycle, from the initial development stages through to approval, insurance reimbursement, and post-market activities. The fees are typically high, involving a fixed monthly rate or a success-based fee.
  • Staff-Type
    • While contract forms can vary, this person works as a member of your company's staff, handling regulatory affairs. Startups often use service consignment contracts (業務委託契約) because they allow for flexible adjustment of the scope of work and duration. These professionals are often hired through recruitment agencies that have a pool of freelance or fractional talent.
  • By matching these support models with your company's needs, you can identify the most suitable option. As mentioned earlier, since information and advice can be obtained for free from public institutions, a common pattern for startups is to have an existing employee take on regulatory duties or to hire someone on a service consignment contract. In addition to this, depending on resources and experience, you might then delegate the hands-on work to an external consultant.


Compare and Consider Outsourcing Options
Once you understand your needs and the type of consulting you're looking for, it's time to consider specific partners. Each has its own characteristics, so compare them carefully.
  • ARO (Academic Research Organization)
    • These are research support organizations, often affiliated with university hospitals. For academia or academia-born startups, they are worth considering as they can be the most cost-effective option.
  • CRO (Contract Research Organization)
    • While their main business is typically conducting clinical trials, most CROs offer regulatory consulting as a functional service. They possess the most know-how regarding clinical trials, so getting a package deal can be very efficient. So-called global CROs with overseas bases can handle regulatory affairs worldwide.
  • Regulatory Consulting Firm
    • These are firms that specialize in regulatory affairs. They tend to be more expensive than freelance consultants, but they are a viable option if you have no internal resources at all. A point of caution is that smaller firms may only be able to handle regulations in Japan, requiring you to find separate consultants for each country.
  • Regulatory Consultant (Freelancer)
    • These are individuals who undertake regulatory work on a freelance basis. They can be more affordable than consulting firms, but quality can be inconsistent, making them a higher-risk option.


Points to Keep in Mind
When selecting a partner, pay close attention to the experience of the individual who will be in charge. Many consultants previously worked in regulatory departments at pharmaceutical companies, but tasks in those departments are often siloed, so few have experience with the entire process.

Furthermore, regulations for pharmaceuticals and medical devices are quite different, and it's rare to find someone who has handled both regulatory affairs and insurance reimbursement.

For these reasons, a firm generally offers more versatility than an individual and may be able to switch your consultant if the initial one isn't a good fit. Be sure to thoroughly verify their experience in the specific tasks you need help with.


Recommendations for Startups
The most cost-effective approach is to handle as much as you can with your existing staff.

Try to make full use of AI. Depending on how you use it, it can provide surprisingly specific and accurate guidance on how to proceed. If you're not sure how to use it, feel free to contact our office.

If you still find that you need help, the basic principle should be to hire people only when absolutely necessary, and preferably on a service consignment contract basis. The reality in Japan is that it is difficult to dismiss permanent employees.

If things still aren't running smoothly after that, then it may be a good idea to bring in an external regulatory consultant.

In any case, the most important thing is to clearly identify which parts of the process your company cannot handle internally. Doing so will naturally make it easier to choose the right path forward.



@K.Kamitani

​
Home
About JPRO
Table of Contents
​
​オフィス概要
​コンテンツ一覧
Ⓒ2025 JPRO
JPRO is a Japan-based business incubator for startups. 
Our approach is unique because our primary focus is on enabling startup self-sufficiency. Our core mission is to help startups optimize their time and cost-efficiency, ensuring they avoid unnecessary expenses and delays. We achieve this by providing centralized access to essential, high quality information—all completely free of charge.
The reliability of our content is exceptionally high, as our information is sourced directly from public institutions and the advice mirrors what we provide in our official advisory roles within these very organizations.
​"You'll likely gain a clear understanding of what needs to be done, enabling you to manage many aspects of your business in-house."
  • Home
    • English Top
    • 日本語トップ
  • Table of Contents (English)
    • Business Setup & Operations >
      • Startup Visa
      • setup corporation, office in Japan
      • Company establishment
      • Life Science Hub, Startup Hub
    • Public Support >
      • List of Public Support Organizations
      • Public Support in Yokohama city
      • Academia-Based Startup Support Guide
      • Mediso free consultation service
    • Regulatory & Compliance >
      • PMDA consultation
      • regulatory considerations when using person infformation
      • Guide to Selecting Regulatory Affairs Staff and Consultants
      • Expedited Review Systems for Pharmaceuticals
      • Guidelines for Establishing Generic Drug Names
      • Combination Products, Combination Medical Devices, Kit Products, Combination Drugs
    • Medical Device, IVD >
      • IVD, LDT, RUO
      • DMAH: Designated Marketing Authorization Holder-Summary Ver.
      • DMAH: Designated Marketing Authorization Holder
      • Combination Products, Combination Medical Devices, Kit Products, Kit Components, Assortment Products
      • How to determine if a product is a medical device
      • medical device classification for combined products
      • medical device class
      • how to confirm JMDN of medical device
      • medical device & IVD reimbursement-Summary Ver.
      • medical device & IVD reimbursemenet
      • insurance reimbursement for SaMD
      • Comparison of Medical Device Definitions: Japan, US, & EU
      • Companion Diagnostics and Gene Panel Testing
    • Pharmaceutical, regenerative medicine >
      • How to determine if a product is a Pharmaceutical Drug
      • Advanced Medical Care System
      • Over-The-Counter (OTC) Drug
      • References on Reimbursement (Cost Calculation) for Regenerative Medical Products
    • Healthcare & Caretech Products >
      • guidance for non medical services
      • Therapeutic Orthoses and Assistive Devices
      • Cosmetics and Quasi-Drugs
      • Overseas Expansion of Non-Medical Device Products as Medical Devices: Learning from the Case of PARO
    • Funding, Partnering & Networking >
      • Utilization of Public Grants and Subsidies
      • J-Ships
      • Partnering
    • Intellectual Property >
      • patent or trade secret?
      • employee invention
      • Matching of Patents Held by Startups and Individuals
    • Legal & Contracts >
      • References for Contracts
      • Guide to Industry-Academia Collaboration Agreements for Academic Researchers
    • Academia & Tech Transfer
    • Licensing, partnering >
      • Introducing Seeds to Pharmaceutical Companies
      • Incentives (Returns) to Licensor Universities
    • References in English
  • コンテンツ一覧
    • 事業設立・運営 >
      • 法人設立
      • ライフサイエンスハブ、スタートアップハブ
    • 公的支援 >
      • 公的支援機関リスト
      • 大学発スタートアップ支援機関・プログラムガイド
      • AMED Medical IP Desk
      • MEDISO活用のススメ
    • 薬事・規制関連 >
      • PMDA RS相談活用のススメ
      • 薬事スタッフ・コンサル選定ガイド
      • 都道府県薬務課一覧
      • コンビネーション製品、組合せ医療機器、キット製品、組合せ医薬品
    • 医薬品、再生医療等製品 >
      • 医薬品の該当性確認方法
      • 医薬品一般的名称設定のガイドライン
      • 医薬品、医療機器等の開発に当たって、参照したい資料
      • 先進医療制度
      • 一般用医薬品(OTC)
      • コンパニオン診断薬と遺伝子パネル検査
      • 再生医療等製品の保険償還(原価計算)に関する参考情報
    • 医療機器、体外診断用医薬品 >
      • 体外診、ラボ開発検査、研究用試薬
      • 医療機器該当性確認ガイド
      • 医療機器と非医療機器の機能が複合した製品は?
      • 医療機器の一般的名称と確認方法
      • 医療機器のクラス分類
      • 医療機器・体外診の保険収載
      • SaMDの保険収載
    • ヘルスケア・ケアテック >
      • 非医療分野の検査サービスを展開する際に注意すべきポイント
      • 治療用装具と補装具
      • 化粧品及び医薬部外品
      • 医療機器とするか、非医療機器とするか
    • 資金調達 >
      • 公的な助成金、補助金の活用
      • 特定投資家向け銘柄制度(J-Ships)
      • パートナリング
      • アカデミア研究者がPIとして応募可能なグラントリスト
      • 海外在住の日本人研究者が日本の助成金を獲得する方法
    • 知的財産 >
      • 特許か?営業秘密か?
      • 職務発明:アカデミア・公的研究機関に所属する研究者が注意すべきポ
      • スタートアップや個人が保有する特許のマッチング
      • ライセンスを受けた大学へのインセンティブ(還元)について
    • 法務・契約 >
      • 契約関連で参考になる公的機関の資料
      • 個人情報を利用する製品開発時の 留意すべき法規制
    • アカデミア、技術移転 >
      • アカデミア研究者のための産学連携契約ガイド
    • ライセンシング、パートナリング >
      • 製薬企業等へのシーズ紹介
    • 海外展開 >
      • 米国展開(主に医療機器)に、読むと役立つ情報リスト
      • 米国FDAにおける、医療機器該当性の確認ステップ
      • 米国における、医療機器の申請データ・試験計画の相談方法((Pre-Submission/Q-Submission
      • 公的機関の海外展開支援
      • 横浜市の公的支援サービス
      • JETROを徹底活用しよう
      • 日米欧での医療機器定義の比較
      • 簡略審査(審査の迅速化)
      • 海外規制等の情報収集
      • 非医療機器製品の海外での医療機器展開
    • オーストラリア >
      • オーストラリア研究開発優遇税制の概要
      • オーストラリア研究開発優遇税制の適用を受けるには
      • オーストラリアでの主要イベント
      • R&D関連の公的機関
      • オーストラリア助成金情報